evidenceacademic
Some experimental peptides may stimulate growth pathways that theoretically increase cancer risk, though long-term human data are lacking.
82% confidence
Certain peptides, especially those related to growth hormone pathways, could promote the growth of existing cancer cells by increasing factors like IGF-1 or VEGF. However, no conclusive long-term human studies have yet confirmed this risk, leaving a cautionary gap in safety knowledge.
Read the full exploration